GALECTO, INC.

BOSTON, MA How do I update this listing?

Galecto is based out of Boston. Galecto, Inc. is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. The firm last filed a Form D notice of exempt offering of securities on 2020-11-05. The notice included securities offered of Equity

Create Alert

Contact Info

galecto, inc.
75 STATE STREET
BOSTON MA    02109

Business Phone: 45-70-70-52-10
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-11-05 D PHARMACEUTICALS Equity 64,199,679 64,199,679 0
2020-01-16 D PHARMACEUTICALS Equity 123,718,248 79,143,223 44,575,025
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
AMIT MUNSHI subscription required
    DIRECTOR
CARL GOLDFISCHER subscription required
    DIRECTOR
CHANDRA LEO subscription required
    DIRECTOR
CHAO Q. KHUONG subscription required
    DIRECTOR
DAVID SHAPIRO subscription required
    DIRECTOR
EREZ CHIMOVITS subscription required
    DIRECTOR
HANS SCHAMBYE subscription required
    EXECUTIVE OFFICER
JAKOB DYNNES HANSEN subscription required
    EXECUTIVE OFFICER
JON FREVE subscription required
    EXECUTIVE OFFICER
KAREN WAGNER subscription required
    DIRECTOR
SOREN LEMONIUS subscription required
    DIRECTOR
SOREN MOLLER subscription required
    DIRECTOR
STEPHAN CHRISTGAU subscription required
    DIRECTOR

Elevate your investments